Hmmm, Yes I have wondered why the big pharma prefers to remain unknown and won't disclose what drugs they are packaging in BioSilicon? The BioSilicon drug delivery licensing busness is all about increasing the patent life of drugs near to the end of their patent period by improving the drug's delivery method. Likewise, it is also about gaining exclusive rights to any existing generic drug by packaging it in BioSilicon to improve its delivery. So these guys may be out to capitalise on more than just their own products. They could be out to steal anyone's drug (generic or near patent expiry) that is suited to improved delivery via BioSilicon. But who cares, as long as psd gets their cut out of it.
PSD
psivida limited
